Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 559-562 , December 2009

Reduced risk of head and neck second primary tumors after radiotherapy

  • Erlend Rennemo

      Affiliations

    • Department of Oto-Rhino-Laryngology/Head and Neck Surgery, Oslo University Hospital – Rikshospitalet, Oslo, Norway
    • Corresponding Author InformationCorresponding author. Address: Department of Oto-Rhino-Laryngology/Head and Neck Surgery, Oslo University Hospital – Rikshospitalet, 0027 Oslo, Norway.
    • ,
  • Ulf Zätterström

      Affiliations

    • Department of Oto-Rhino-Laryngology/Head and Neck Surgery, Oslo University Hospital – Rikshospitalet, Oslo, Norway
    • ,
  • Jan Evensen

      Affiliations

    • Oslo University Hospital – The Norwegian Radium Hospital, Oslo, Norway
    • ,
  • Morten Boysen

      Affiliations

    • Department of Oto-Rhino-Laryngology/Head and Neck Surgery, Oslo University Hospital – Rikshospitalet, Oslo, Norway
    • Faculty of Medicine, University of Oslo, Norway

Received 9 December 2008 ,Revised 25 July 2009 ,Accepted 11 August 2009.

References 

  1. Yamamoto E, Shibuya H, Yoshimura RI, Miura M. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer. 2002;94:2007–2014
  2. Rennemo E, Zatterstrom U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope. 2008;118:1350–1356
  3. Jones AS, et al. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995;75:1343–1353
  4. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767
  5. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer. 2005;5:127–135
  6. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953;6:963–968
  7. Braakhuis BJ, Brakenhoff RH, Leemans CR. Second field tumors: a new opportunity for cancer prevention?. Oncologist. 2005;10:493–500
  8. Corvo R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol. 2007;85:156–170
  9. Little MP. Cancer after exposure to radiation in the course of treatment for benign and malignant disease. Lancet Oncol. 2001;2:212–220
  10. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer. 1932;16:1358–1414
  11. Bland JM, Altman DG. Survival probabilities (the Kaplan–Meier method). BMJ. 1998;317:1572
  12. Singh B. Molecular pathogenesis of head and neck cancers. J Surg Oncol. 2008;97:634–639
  13. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359:1143–1154
  14. Fletcher GH. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer. 1972;29:1450–1454
  15. Gewirtz DA, Holt SE, Elmore LW. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol. 2008;76:947–957
  16. Collado M, et al. Tumour biology: senescence in premalignant tumours. Nature. 2005;436:642
  17. Roberson RS, Kussick SJ, Vallieres E, Chen SY, Wu DY. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res. 2005;65:2795–2803
  18. Beausejour CM, et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 2003;22:4212–4222
  19. Malard O, et al. Radiation-induced cancers of the pharynx and larynx: a study of five clinical cases. Clin Otolaryngol. 2002;27:68–74
  20. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol. 2009;91:4–15discussion 1–3
  21. Rusthoven K, Chen C, Raben D, Kavanagh B. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis. Int J Radiat Oncol Biol Phys. 2008;71:192–198
  22. Hashibe M, et al. Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett. 2005;220:185–195
  23. Khuri FR, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2001;10:823–829

PII: S0167-8140(09)00444-7

doi: 10.1016/j.radonc.2009.08.005

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 559-562 , December 2009

Article Tools

* Image Usage & Resolution